Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

NCT06498635 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

306

Enrollment

NIH

Sponsor class

Conditions

Lung Non-Small Cell Carcinoma
Stage II Lung Cancer AJCC v8
Stage IIIA Lung Cancer AJCC v8
Stage IIIB Lung Cancer AJCC v8

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
BIOLOGICAL: Durvalumab
OTHER: Patient Observation
OTHER: Questionnaire Administration

Sponsor

National Cancer Institute (NCI)